Precigen (PGEN) Deferred Taxes (2015 - 2024)
Precigen's (PGEN) quarterly Deferred Taxes came in at -$89000.0 in Q4 2024, up 74.79% year-on-year from -$50919.0 in Q1 2024, and down 841.67% on a QoQ basis from $12000.0 in Q3 2024.
Precigen (PGEN) Deferred Taxes (2015 - 2024) Analysis & Trends
Precigen (PGEN) has 10 years of Deferred Taxes data on file, last reported at -$89000.0 in Q4 2024.
- On a quarterly basis, Deferred Taxes rose 74.79% year-over-year to -$89000.0 in Q4 2024; TTM through Sep 2025 was -$89000.0, a 95.68% increase from a year earlier, with the FY2024 full-year figure at -$1.8 million, down 274.74% from the prior year.
- Deferred Taxes for Q4 2024 stood at -$89000.0, down from $12000.0 in the prior quarter.
- Over the last five years, Deferred Taxes for PGEN reached as high as $48000.0 in Q4 2020 and fell as low as -$1.7 million in Q2 2024.
- Historically, Deferred Taxes has averaged -$144578.9 across 5 years, with a median of -$56000.0 in 2021.
- Across the five-year window, Deferred Taxes plunged 3041.67% in 2023 and soared 192.31% in 2024, its largest moves.
- Year by year, Deferred Taxes stood at $48000.0 in 2020, then tumbled by 72.92% to $13000.0 in 2021, then declined by 7.69% to $12000.0 in 2022, then plunged by 3041.67% to -$353000.0 in 2023, then surged by 74.79% to -$89000.0 in 2024.
- Per Business Quant data, the three most recent Deferred Taxes figures were -$89000.0 in Q4 2024, $12000.0 in Q3 2024, and -$1.7 million in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -188,883.60 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -65.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 96.00 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Precigen | 1.96 Bn | 1.96 Bn | 20.69 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -89,000.00 |
| Sep 30, 2024 | 12,000.00 |
| Jun 30, 2024 | -1.69 Mn |
| Mar 31, 2024 | -29,000.00 |
| Dec 31, 2023 | -353,000.00 |
| Sep 30, 2023 | -13,000.00 |
| Jun 30, 2023 | -58,000.00 |
| Mar 31, 2023 | -55,000.00 |
| Dec 31, 2022 | 12,000.00 |
| Sep 30, 2022 | -50,000.00 |
| Jun 30, 2022 | -54,000.00 |
| Mar 31, 2022 | -58,000.00 |
| Dec 31, 2021 | 13,000.00 |
| Sep 30, 2021 | -61,000.00 |
| Jun 30, 2021 | -63,000.00 |
| Mar 31, 2021 | -56,000.00 |
| Dec 31, 2020 | 48,000.00 |
| Sep 30, 2020 | -68,000.00 |
| Jun 30, 2020 | -136,000.00 |
| Dec 31, 2019 | -2.23 Mn |